Involvement of casein kinase Iε in cytokine-induced granulocytic differentiation

Blood

Volumn 103, Issue 8, 2004, Pages 2997-3004

  Okamura, Atsuo ^a   Iwata, Nobuko ^a   Nagata, Aki ^a   Tamekane, Akira ^a   Shimoyama, Manabu ^a   Gomyo, Hiroshi ^a   Yakushijin, Kimikazu ^a   Urahama, Norinaga ^a   Hamaguchi, Miyuki ^a   Fukui, Chie ^a   Chihara, Kazuo ^a   Ito, Mitsuhiro ^a   Matsui, Toshimitsu ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CASEIN KINASE I; CASEIN KINASE IDELTA; CASEIN KINASE IEPSILON; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 3; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 3; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; DOWN REGULATION; GRANULOCYTE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 11144358617     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-08-2768     Document Type: Article

References (67)

1. Gross SD, Anderson RA. Casein kinase I: spatial organization and positioning of a multifunctional protein kinase family. Cell Signal. 1998;10:699-711.
2. Vielhaber E, Virshup DM. Casein kinase I: from obscurity to center stage. IUBMB Life. 2001;51:73-78.
3. Rowles J, Slaughter C, Moornaw C, Hsu J, Cobb MH. Purification of casein kinase I and isolation of cDNAs encoding multiple casein kinase I-like enzymes. Proc Natl Acad Sci U S A. 1991;88:9548-9552.
4. Graves PR, Roach PJ. Role of COOH-terminal phosphorylation in the regulation of casein kinase Iδ. J Biol Chem. 1995;270:21689-21694.
5. Fish KJ, Cegielska A, Getman ME, Landes GM, Virshup DM. Isolation and characterization of human casein kinase Iε(CKI), a novel member of the CKI gene family. J Biol Chem. 1995;270:14875-14883.
6. Zhai L, Graves PR, Robinson LC, et al. Casein kinase Iγ subfamily: molecular cloning, expression, and characterization of three mammalian isoforms and complementation of defects in the Saccharomyces cerevisiae YCK genes. J Biol Chem. 1995;270:12717-12724.
7. Graves PR, Haas DW, Hagedom CH, DePaoli-Roach AA, Roach PJ. Molecular cloning, expression, and characterization of a 49-kilodalton casein kinase 1 isoform from rat testis. J Biol Chem. 1993;268:6394-6401.
8. Vancura A, Sessler A, Leichus B, Kuret J. A prenylation motif is required for plasma membrane localization and biochemical function of casein kinase I in budding yeast. J Biol Chem. 1994;269:19271-19278.
9. Wang PC, Vancura A, Desai A, Carmel G, Kuret J. Cytoplasmic forms of fission yeast casein kinase-1 associate primarily with the particulate fraction of the cell. J Biol Chem. 1994;269:12014-12023.
10. Cegielska A, Gietzen KF, Rivers A, Virshup DM. Autoinhibition of casein kinase Iε (CKI epsilon) is relieved by protein phosphatases and limited proteolysis. J Biol Chem. 1998;273:1357-1364.
11. Hoekstra MF, Liskay RM, Ou AC, DeMaggio AJ, Burbee DG, Heffron F. HRR25, a putative protein kinase from budding yeast: association with repair of damaged DNA. Science. 1991;253:1031-1034.
12. Dhillon N, Hoekstra MF. Characterization of two protein kinases from Schizosaccharomyces pombe involved in the regulation of DNA repair. EMBO J. 1994;13:2777-2788.
13. Wang X, Hoekstra MF, DeMaggio AJ, et al. Prenylated isoforms of yeast casein kinase I, including the novel Yck3p, suppress the gcs 1 blockage of cell proliferation from stationary phase. Mol Cell Biol. 1996;16:5375-5385.
14. Panek HR, Stepp JD, Engle HM, et al. Suppressors of YCK-encoded yeast casein kinase 1 deficiency define the four subunits of a novel clathrin AP-like complex. EMBO J. 1997;16:4194-4204.
15. Robinson LC, Menold MM, Garrett S, Culbertson MR. Casein kinase I-like protein kinases encoded by YCK1 and YCK2 are required for yeast morphogenesis. Mol Cell Biol. 1993;13:2870-2881.
16. Cegielska A, Virshup DM. Control of simian virus 40 DNA replication by the HeLa cell nuclear kinase casein kinase I. Mol Cell Biol. 1993;13:1202-1211.
17. Gross SD, Loijens JC, Anderson RA. The casein kinase Iα isoform is both physically positioned and functionally competent to regulate multiple events of mRNA metabolism. J Cell Sci. 1999;112:2647-2656.
18. Fu Z, Green CL, Bennett GS. Relationship between casein kinase I isoforms and a neurofilament-associated kinase. J Neurochem. 1999;73:830-838.
19. Behrend L, Stoter M, Kurth M, et al. Interaction of casein kinase 1 delta (CK1δ) with post-Golgi structures, microtubules and the spindle apparatus. Eur J Cell Biol. 2000;79:240-251.
20. Faundez VV, Kelly RB. The AP-3 complex required for endosomal synaptic vesicle biogenesis is associated with a casein kinase Iα-like isoform. Mol Biol Cell. 2000;11:2591-2604.
21. Gross SD, Simerly C, Schatten G, Anderson RA. A casein kinase I isoform is required for proper cell cycle progression in the fertilized mouse oocyte. J Cell Sci. 1997;110:3083-3090.
22. Beyaert R, Vanhaesebroeck B, Declercq W, et al. Casein kinase-1 phosphorylates the p75 tumor necrosis factor receptor and negatively regulates tumor necrosis factor signaling for apoptosis. J Biol Chem. 1995; 270:23293-23299.
23. Lussier G, Larose L. A casein kinase I activity is constitutively associated with Nck. J Biol Chem. 1997;272:2688-2694.
24. Tobin AB, Totty NF, Sterlin AE, Nahorski SR. Stimulus-dependent phosphorylation of G-protein-coupled receptors by casein kinase 1α. J Biol Chem. 1997;272:20844-20849.
25. Sakaguchi K, Saito S, Higashimoto Y, Roy S, Anderson CW, Appella E. Damage-mediated phosphorylation of human p53 threonine 18 through a cascade mediated by a casein 1-like kinase: effect on Mdm2 binding. J Biol Chem. 2000;275:9278-9283.
26. Vielhaber E, Eide E, Rivers A, Gao ZH, Virshup DM. Nuclear entry of the circadian regulator mPER1 is controlled by mammalian casein kinase Iε. Mol Cell Biol. 2000;20:4888-4899.
27. Zhu J, Shibasaki F, Price R, et al. Intramolecular masking of nuclear import signal on NF-AT4 by casein kinase I and MEKK1. Cell. 1998;93:851-861.
28. Keesler GA, Camacho F, Guo Y, Virshup D, Mondadori C, Yao Z. Phosphorylation and destabilization of human period I clock protein by human casein kinase Iε. Neuroreport. 2000;11:951-955.
29. Kloss B, Price JL, Saez L, et al. The Drosophila clock gene double-time encodes a protein closely related to human casein kinase Iε. Cell. 1998;94:97-107.
30. Lowrey PL, Shimomura K, Antoch MP, et al. Positional syntenic cloning and functional characterization of the mammalian circadian mutation tau. Science. 2000;288:483-492.
31. Peters JM, McKay RM, McKay JP, Graff JM. Casein kinase I transduces Wnt signals. Nature. 1999;401:345-350.
32. Sakanaka C, Leong P, Xu L, Harrison SD, Williams LT. Casein kinase Iε in the wnt pathway: regulation of β-catenin function. Proc Natl Acad Sci U S A. 1999;96:12548-12552.
33. Rivers A, Gietzen KF, Vielhaber E, Virshup DM. Regulation of casein kinase Iε and casein kinase Iδ by an in vivo futile phosphorylation cycle. J Biol Chem. 1998;273:15980-15984.
34. Knippschild U, Milne DM, Campbell LE, et al. p53 is phosphorylated in vitro and in vivo by the delta and epsilon isoforms of casein kinase 1 and enhances the level of casein kinase 1 delta in response to topoisomerase-directed drugs. Oncogene. 1997;15:1727-1736.
35. Camacho F, Cilio M, Guo Y, et al. Human casein kinase Iδ phosphorylation of human circadian clock proteins period 1 and 2. FEBS Lett. 2001;489:159-165.
36. McKay RM, Peters JM, Gratt JM. The casein kinase I family: roles in morphogenesis. Dev Biol. 2001;235:378-387.
37. Iwata N, Murayama T, Matsumori Y, et al. Autocrine loop through cholecystokinin-B/gastrin receptors involved in growth of human leukemia cells. Blood. 1996;88:2683-2689.
38. Matsuoka H, Iwata N, Ito M, et al. Expression of a kinase-defective Eph-like receptor in the normal human brain. Biochem Biophys Res Commun. 1997;235:487-492.
39. Nagata A, Ito M, Iwata N, et al. G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo. Proc Natl Acad Sci U S A. 1996;93:11825-11830.
40. Rane SG, Reddy EP. JAKs, STATs and Src kinases in hematopoiesis. Oncogene. 2002;21:3334-3358.
41. Krebs DL, Hilton DJ. SOCS proteins: negative regulators of cytokine signaling. Stem Cells. 2001;19:378-387.
42. Croker BA, Krebs DL, Zhang JG, et al. SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol. 2003;4:540-545.
43. Suzuki A, Hanada T, Mitsuyama K, et al. CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation. J Exp Med. 2001;193:471-481.
44. Denson LA, Held MA, Menon RK, Frank SJ, Parlow AF, Arnold DL. Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3. Am J Physiol Gastrointest Liver Physiol. 2003;284:G646-G654.
45. Zhang JG, Farley A, Nicholson SE, et al. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc Natl Acad Sci U S A. 1999;96:2071-2076.
46. Sasaki A, Inagaki-Ohara K, Yoshida T, et al. The N-terminal truncated isoform of SOCS3 translated from an alternative initiation AUG codon under stress conditions is stable due to the lack of a major ubiquitination site, Lys-6. J Biol Chem. 2003;278:2432-2436.
47. Sadot E, Simcha I, Iwai K, Ciechanover A, Geiger B, Ben-Ze'ev A. Differential interaction of plakoglobin and beta-catenin with the ubiquitin-proteasome system. Oncogene. 2000;19:1992-2001.
48. Rubinfeld B, Tice DA, Polakis P. Axin-dependent phosphorylation of the adenomatous polyposis coli protein mediated by casein kinase 1ε. J Biol Chem. 2001;276:39037-39045.
49. Gao ZH, Seeling JM, Hill V, Yochum A, Virshup DM. Casein kinase I phosphorylates and destabilizes the β-catenin degradation complex. Proc Natl Acad Sci U S A. 2002;99:1182-1187.
50. Nicholson SE, Novak U, Ziegler SF, Layton JE. Distinct regions of the granulocyte colony-stimulating factor receptor are required for tyrosine phosphorylation of the signaling molecules JAK2, Stat3, and p42, p44MAPK. Blood. 1995;86:3698-3704.
51. McKay RM, Peters JM, Graff JM. The casein kinase I family in Wnt signaling. Dev Biol. 2001;235:388-396.
52. Ihle JN. Signaling by the cytokine receptor superfamily in normal and transformed hematopoietic cells. Adv Cancer Res. 1996;68:23-65.
53. de Groot RP, Coffer PJ, Koenderman L. Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family. Cell Signal. 1998;10:619-628.
54. Geijsen N, Koenderman L, Coffer PJ. Specificity in cytokine signal transduction: lessons learned from the IL-3/IL-5/GM-CSF receptor family. Cytokine Growth Factor Rev. 2001;12:19-25.
55. Ward AC, Smith L, de Koning JP, van Aesch Y, Touw IP. Multiple signals mediate proliferation, differentiation, and survival from the granulocyte colony-stimulating factor receptor in myeloid 32D cells. J Biol Chem. 1999;274:14956-14962.
56. Mui AL, Wakao H, O'Farrell AM, Harada N, Miyajima A. Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologs. EMBO J. 1995;14:1166-1175.
57. Hortner M, Nielsen U, Mayr LM, Johnston JA, Heinrich PC, Haan S. Suppressor of cytokine signaling-3 is recruited to the activated granulocyte-colony stimulating factor receptor and modulates its signal transduction. J Immunol. 2002;169:1219-1227.
58. Hermans MH, Van De Geijn GJ, Antonissen C, et al. Signaling mechanisms coupled to tyrosines in the granulocyte colony-stimulating factor receptor orchestrate G-CSF-induced expansion of myeloid progenitor cells. Blood. 2003;101:2584-2590.
59. Flotow H, Graves PR, Wang AQ, Fiol CJ, Roeske RW, Roach PJ. Phosphate groups as substrate determinants for casein kinase I action. J Biol Chem. 1990;265:14264-14269.
60. Sasaki A, Yasukawa H, Shouda T, Kitamura T, Dikic I, Yoshimura A. CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2. J Biol Chem. 2000;275:29338-29347.
61. Pezet A, Favre H, Kelly PA, Edery M. Inhibition and restoration of prolactin signal transduction by suppressors of cytokine signaling. J Biol Chem. 1999;274:24497-24502.
62. Masuhara M, Sakamoto H, Matsumoto A, et al. Cloning and characterization of novel CIS family genes. Biochem Biophys Res Commun. 1997;239:439-446.
63. Suzuki R, Sakamoto H, Yasukawa H, et al. CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukemia cells. Oncogene. 1998;17:2271-2278.
64. Sasaki A, Yasukawa H, Suzuki A, et al. Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain. Genes Cells. 1999;4:339-351.
65. Favre H, Benhamou A, Finidori J, Kelly PA, Edery M. Dual effects of suppressor of cytokine signaling (SOCS-2) on growth hormone signal transduction. FEBS Lett. 1999;453:63-66.
66. Kirito K, Watanabe T, Sawada K, et al. Thrombopoietin regulates Bcl-xL gene expression through Stat5 and Phosphatidylinositol 3-kinase activation pathways. J Biol Chem. 2002;277:8329-8337.
67. Reya T, Duncan AW, Ailles L, et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature. 2003;423:409-414.